TRANSCODE THERAPEUTICS, INC. - Common Stock, $0.0001 par value (RNAZ)

Historical Holders from Q4 2024 to Q2 2025

Symbol
RNAZ on Nasdaq
CUSIP
89357L402
Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
700K
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
0
Holdings value
$0
Grand Portfolio weight change
0%
Number of holders
0
Number of sells
-15
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TRANSCODE THERAPEUTICS, INC. - Common Stock, $0.0001 par value (RNAZ)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SABBY MANAGEMENT, LLC 9.9% $27.8K 69.6K SABBY MANAGEMENT, LLC Dec 31, 2024
Tracy Thomas Joseph 5% $14K 35K Thomas Joseph Tracy Mar 7, 2025
Anson Funds Management LP 0.1% -98% $9.49K -$30.2K 27.1K -76.1% Anson Funds Management LP Jun 30, 2025

Institutional Holders of TRANSCODE THERAPEUTICS, INC. - Common Stock, $0.0001 par value (RNAZ)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 0 $0 -$1.05M 0
2025 Q1 2.13M $1.05M +$1.05M $0.50 15
2024 Q4 9.91K $33.4K +$33.4K $3.37 4